[Influence of deficient kidney function on behavior of glipizide (hypoglycemic sulfonylurea) and its metabolites].
作者信息
Fabre J, Balant L, Zahnd G
出版信息
J Urol Nephrol (Paris). 1973 Apr-May;79(4):380-1.
PMID:4720133
Abstract
摘要
相似文献
1
[Influence of deficient kidney function on behavior of glipizide (hypoglycemic sulfonylurea) and its metabolites].[肾功能不全对格列吡嗪（降糖磺脲类药物）及其代谢产物行为的影响]
J Urol Nephrol (Paris). 1973 Apr-May;79(4):380-1.
2
[Oral antidiabetics of the sulfonylurea group and their problems in therapy].[磺脲类口服降糖药及其治疗中的问题]
Z Gerontol. 1980 Jan-Feb;13(1):45-51.
3
Influence of glycemic control on the development of diabetic cardiovascular and kidney disease.血糖控制对糖尿病心血管和肾脏疾病发展的影响。
Cardiol Clin. 2010 Aug;28(3):497-516. doi: 10.1016/j.ccl.2010.04.008.
4
[Glipizide, a new sulfonylurea in the treatment of diabetes mellitus].格列吡嗪，一种治疗糖尿病的新型磺脲类药物
Prensa Med Mex. 1973 May-Jun;38(5):211-4.
5
[Complications in the therapy of diabetes using oral hypoglycemic agents].
Minerva Med. 1974 Dec 15;65(90):4769-71.
6
[The effect of renal insufficiency on the hypoglycemic action of sulfonylureas. Kinetics of chlorpropamide in a case of nephropathy].
Schweiz Med Wochenschr. 1972 Apr 22;102(16):570-8.
7
[Risks of peroral treatment of diabetes].[糖尿病口服治疗的风险]
Vnitr Lek. 1983 Nov;29(11):1114-8.
8
[Indications and limitations of oral hypoglycemic agents in the treatment of diabetes mellitus].[口服降糖药治疗糖尿病的适应证及局限性]
Cah Med. 1972 Nov 15;13(14):999-1006.
9
10
The role of hypoglycemic sulphonylureas in arrhythmias contributing to the mortality in acute myocardial ischemia.
Acta Physiol Hung. 1990;75 Suppl:175-6.
引用本文的文献
1
Clinical experience with glipizide in the treatment of mostly complicated diabetes.格列吡嗪治疗大多为复杂性糖尿病的临床经验。
Diabetologia. 1973 Sep:356-63. doi: 10.1007/BF01218447.
Zotero 插件